Hoffmann-La Roche Inc. received FDA clearance to sell Pegasys, a pegylated interferon for the treatment of hepatitis C, making it the second drug on the market for this disease developed using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results